8-K Item 2.05: Costs Associated with Exit or Disposal Activities

What it discloses. The company committed to an exit or disposal plan, such as a restructuring, facility closure or workforce reduction, under which it expects to incur material charges.

What to read. The expected total charges by major type and the expected timing.

How to read an 8-K in 10 minutes · Official Form 8-K instructions (SEC)

Latest filings with Item 2.05

Accepted (ET)	Company	Form	Items	Filing
2026-11-12 09:19	UPWORK, INC UPWK	8-K/A	2.05 Exit or restructuring costs	Details
2026-11-12 08:00	PVH CORP. /DE/ PVH	8-K	2.05 Exit or restructuring costs	Details
2026-11-10 16:12	GrowGeneration Corp. GRWG	8-K	2.05 Exit or restructuring costs 7.01 Reg FD disclosure	Details
2026-11-10 16:05	Phunware, Inc. PHUN	8-K	2.05 Exit or restructuring costs	Details
2026-11-10 08:06	Coursera, Inc. COUR	8-K	2.05 Exit or restructuring costs	Details
2026-11-09 16:07	Artiva Biotherapeutics, Inc. ARTV	8-K/A	2.05 Exit or restructuring costs	Details
2026-11-05 16:04	SOUNDHOUND AI, INC. SOUN	8-K	2.02 Earnings release 2.05 Exit or restructuring costs	Details
2026-11-05 16:01	Acumen Pharmaceuticals, Inc. ABOS	8-K	1.02 Agreement terminated 2.05 Exit or restructuring costs	Details
2026-11-05 08:01	Portillo's Inc. PTLO	8-K	2.02 Earnings release 2.05 Exit or restructuring costs 7.01 Reg FD disclosure	Details
2026-11-05 06:47	Eos Energy Enterprises, Inc. EOSE	8-K	2.02 Earnings release 2.05 Exit or restructuring costs	Details
2026-11-04 16:38	STERIS plc STE	8-K	2.02 Earnings release 2.05 Exit or restructuring costs	Details
2026-11-04 16:16	Mueller Water Products, Inc. MWA	8-K	2.02 Earnings release 2.05 Exit or restructuring costs 7.01 Reg FD disclosure	Details
2026-11-03 16:07	Ultragenyx Pharmaceutical Inc. RARE	8-K	2.01 Acquisition or sale done 2.02 Earnings release 2.05 Exit or restructuring costs	Details
2026-11-03 08:20	Vital Farms, Inc. VITL	8-K/A	2.05 Exit or restructuring costs	Details
2026-11-02 09:10	KIMBERLY CLARK CORP KMB	8-K	2.01 Acquisition or sale done 2.05 Exit or restructuring costs 5.02 Executive or director change 5.03 Charter or bylaw change 7.01 Reg FD disclosure	Details
2026-10-30 17:24	Vistagen Therapeutics, Inc. VTGN	8-K	2.05 Exit or restructuring costs 8.01 Other events	Details
2026-10-30 16:30	FTI CONSULTING, INC FCN	8-K	2.02 Earnings release 2.05 Exit or restructuring costs 7.01 Reg FD disclosure	Details
2026-10-28 16:34	LENZ Therapeutics, Inc. LENZ	8-K	2.02 Earnings release 2.05 Exit or restructuring costs 5.02 Executive or director change	Details
2026-10-28 09:05	DROPBOX, INC. DBX	8-K	2.02 Earnings release 2.05 Exit or restructuring costs 5.02 Executive or director change	Details
2026-10-27 08:30	Artiva Biotherapeutics, Inc. ARTV	8-K	2.02 Earnings release 2.05 Exit or restructuring costs	Details
2026-10-26 16:42	GRAFTECH INTERNATIONAL LTD EAF	8-K/A	2.05 Exit or restructuring costs	Details
2026-10-26 16:09	Maplebear Inc. CART	8-K	2.05 Exit or restructuring costs	Details
2026-10-22 09:07	EBAY INC EBAY	8-K	2.02 Earnings release 2.05 Exit or restructuring costs	Details
2026-10-22 07:01	FRACTYL HEALTH, INC. GUTS	8-K	2.05 Exit or restructuring costs 5.02 Executive or director change 8.01 Other events	Details
2026-10-20 17:00	NORTHPOINTE BANCSHARES INC NPB	8-K	2.02 Earnings release 2.05 Exit or restructuring costs 7.01 Reg FD disclosure	Details
2026-10-20 07:02	Flutter Entertainment plc FLUT	8-K	2.05 Exit or restructuring costs 7.01 Reg FD disclosure	Details
2026-10-19 09:22	EyePoint, Inc. EYPT	8-K	2.02 Earnings release 2.05 Exit or restructuring costs 8.01 Other events	Details
2026-10-14 10:31	DAKTRONICS INC /SD/ DAKT	8-K	2.05 Exit or restructuring costs 2.06 Impairment 8.01 Other events	Details
2026-10-13 17:25	Premier Air Charter Holdings Inc. PREM	8-K	1.02 Agreement terminated 2.04 Debt acceleration 2.05 Exit or restructuring costs 5.02 Executive or director change	Details
2026-10-13 08:00	MESA LABORATORIES INC /CO/ MLAB	8-K	2.05 Exit or restructuring costs 7.01 Reg FD disclosure	Details